17-18-19 OCT 2024

BBFEC – Dhaka – Bangladesh
(Bangabandhu Bangladesh China Friendship Exhibition Centre)


Over the past two decades, Gujarat has become one of the most preferred locations for industrial investment in India. Gujarat has achieved an annual growth rate of over 10% p.a. over the past five years and is one of the most industrialized states of India. It accounts for 16% of the nation’s industrial production and 22% of its exports. Gujarat possesses several advantages which have enabled it to chart a path of rapid growth and industrialization such as sound infrastructure facilities, availability of skilled and semi-skilled manpower, excellent domestic and international connectivity and rich natural resources.

The key differentiating factor has been Gujarat’s investor-friendly policy towards industrial development. These have resulted in Gujarat evolving as the hub of India’s chemical and petrochemical industry – with the state accounting for more than half of India’s total chemical industry and ~63% of total national petrochemical production. The chemical industry is today the largest and fastest growing component of Gujarat’s manufacturing sector.

Gujarat leads India in Pharmaceutical, Petrochemicals, CRO, Chemical Industry & Agriculture and enjoys the share between 35%- 44% of the national share over last two decade. Ahmedabad, Baroda, Surat, Dahej, Rajkot, Mehsana, Vapi, Valsad, Ankleshwar, Bharuch are a few gems in this very prosperous state of Gujrat that stand out & create an aura of opportunity.
“An exhibition encompassing all these along with the neighbouring states is bound to have more reach and is surely going to create a mark in the exhibition industry.”

Asia Labex


  • Gujarat Accounting for nearly 42% share of India’s pharmaceutical turnover
  • Gujarat’s pharmaceutical industry has evolved into an innovation-driven, Knowledge focused industry.
  • In, recent years Gujarat develop into an ideal location for global clinical research &
  • Pharmaceutical development It is an established manufacturing base for bulk drugs and formulations – With its inherent competitive advantages – is poised to capture emerging global Opportunities to become a global pharmaceuticals hub. The emergence of SEZs is likely to create a pharma behemoth-with scale and infrastructure on par with International standards, that will enable it to compete in the global marketplace.
Open chat
How Can I Help you ?